CCO Oncology Podcast

Clinical Care Options
  • 0.0 (0)
  • COURSES
  • EVERY TWO MONTHS
CCO Oncology Podcast

Updates on new data and best practices in the care of patients with cancer across a wide variety of solid tumors and hematologic malignancies from Clinical Care Options. Gain practical clinical insights and strategies and earn CME/CE credit for selected episodes.

  1. Clinical Highlights: Oral SERDs for Patients With HR+/HER2- ESR1-Mutated Advanced Breast Cancer

    6 DAYS AGO

    Clinical Highlights: Oral SERDs for Patients With HR+/HER2- ESR1-Mutated Advanced Breast Cancer

    Audio podcast with key highlights on current and emerging data for the use of oral SERDS in patients with HR+/HER2- ESR1-mutated advanced breast cancer. Listen to experts put new trial results into context and cover practical perspectives and takeaway points for your everyday practice.

    36 min
  2. Relapsed/Refractory Multiple Myeloma: Role and Safety of Bispecific Antibodies

    22/10/2024

    Relapsed/Refractory Multiple Myeloma: Role and Safety of Bispecific Antibodies

    Caitlin Costello, MD, discusses the role and safety of bispecific antibodies approved for the treatment of relapsed/refractory multiple myeloma as well as emerging data and clinical trials with this treatment approach.

    21 min
  3. Gastroenteropancreatic Neuroendocrine Tumors: Diagnosis, Findings, and Recommendations

    16/10/2024

    Gastroenteropancreatic Neuroendocrine Tumors: Diagnosis, Findings, and Recommendations

    Listen as Thor R. Halfdanarson, MD, and Jonathan Strosberg, MD, discuss the diagnosis and typical presenting symptoms of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) as well as findings from recent phase III studies including NETTER-2 and CABINET. Notable clinical pearls regarding GEP-NET therapies and current guidelines for GEP-NET care and monitoring are also highlighted.

    28 min
  4. ESMO 2024 Congress Highlights in Gynecologic Cancer: New Data Informing Treatment of Ovarian, Endometrial, and Cervical Cancers

    01/10/2024

    ESMO 2024 Congress Highlights in Gynecologic Cancer: New Data Informing Treatment of Ovarian, Endometrial, and Cervical Cancers

    Audio podcast with key clinical highlights for gynecologic cancers from the 2024 ESMO congress. Listen to experts put new trial results into context and share their perspectives and takeaway points for integrating new data into your everyday practice.

    31 min
  5. A Cancer Conversation: Optimizing the Care of Patients With CLL Through a Deeper Understanding of BTK Inhibitor Resistance

    30/09/2024

    A Cancer Conversation: Optimizing the Care of Patients With CLL Through a Deeper Understanding of BTK Inhibitor Resistance

    Listen to expert perspectives on selecting optimal therapy for patients with CLL, with a focus on how BTK inhibitor resistance mutations are assessed and how they affect therapy choice.

    33 min
  6. Available and Emerging Therapies for Progressive/Recurrent ROS1-Altered Advanced NSCLC

    06/09/2024

    Available and Emerging Therapies for Progressive/Recurrent ROS1-Altered Advanced NSCLC

    Audio podcast with highlights from a live webinar covering available clinical data and approved treatments options for progressive ROS1-altered advanced non-small-cell lung cancer (NSCLC), including emerging options on the horizon. Listen to the experts review and discuss their perspectives and summarize the clinical data in support of guideline second-line and beyond treatments.

    14 min
  7. Available Clinical Data and Approved First-line Treatments for ROS1-Altered Advanced NSCLC

    05/09/2024

    Available Clinical Data and Approved First-line Treatments for ROS1-Altered Advanced NSCLC

    Audio podcast with highlights from a live webinar covering available clinical data and approved treatments for ROS1-altered TKI-naive advanced non-small-cell lung cancer (NSCLC). Listen to the experts review and discuss their perspectives and summarize clinical data in support of guideline-recommended first-line treatment approaches.

    14 min
  8. ROS1-Alterations and Molecular Testing in Advanced NSCLC

    28/08/2024

    ROS1-Alterations and Molecular Testing in Advanced NSCLC

    Audio podcast with clinical highlights from a live webinar covering current recommended molecular testing for ROS1-alterations in patients with non-small-cell lung cancer. Listen to the experts review and discuss their perspectives and summarize current best practices.

    16 min
See All (186)

About

Updates on new data and best practices in the care of patients with cancer across a wide variety of solid tumors and hematologic malignancies from Clinical Care Options. Gain practical clinical insights and strategies and earn CME/CE credit for selected episodes.

Information

  • Creator
    Clinical Care Options
  • Years Active
    2020 - 2025
  • Episodes
    186
  • Rating
    Clean
  • Copyright
    © 2020 CCO Oncology Podcast
  • Show Website
    CCO Oncology Podcast

You Might Also Like

To listen to explicit episodes, sign in.

Stay up to date with this show

Sign in or sign up to follow shows, save episodes and get the latest updates.
Select a country or region

Africa, Middle East, and India

Asia Pacific

Europe

Latin America and the Caribbean

The United States and Canada